Home  >  Products  >  IKBKE (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon ) Blocking Peptide (the N terminal of IKBKE)(100ug)
IKBKE (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon ) Blocking Peptide (the N terminal of IKBKE)(100ug)

IKBKE (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon ) Blocking Peptide (the N terminal of IKBKE)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IKBKE Antibody (ARP63182_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63182
Size: 100ug
Weight: 69kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: IKBKE is a noncanonical I-kappa-B kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines.
Alternative names: IKK-i; IKKE; IKKI; KIAA0151; MGC125294; MGC125295; MGC125297